Annie Borel‐Derlon

2.1k citations

44 papers · 1.3k indexed · h-index 17

Hematology top 0.5%
Cardiology and Cardiovascular Medicine top 10%
Internal Medicine top 2%
Genetics top 5%
Surgery

Co-authors: Jenny Goudemand Thierry Lambert Jeanne‐Yvonne Borg Yohann Repessé S. Claeyssens Hérvè Chambost Sébastien Lacroix‐Desmazes Srini V. Kaveri
Topics: Platelet Disorders and Treatments (27 papers)Hemophilia Treatment and Research (24 papers)Blood Coagulation and Thrombosis Mechanisms (12 papers)
Cited by: Hematology Internal Medicine Genetics
Journals: SHILAP Revista de lepidopterologíaBlood The Journal of Immunology
Partner nations: France United States Germany

In The Last Decade

Annie Borel‐Derlon

40 papers receiving 1.3k citations

Peers

Countries citing papers authored by Annie Borel‐Derlon

Since Specialization

Citations

This map shows the geographic impact of Annie Borel‐Derlon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Borel‐Derlon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Borel‐Derlon more than expected).

Fields of papers citing papers by Annie Borel‐Derlon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie Borel‐Derlon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Borel‐Derlon. The network helps show where Annie Borel‐Derlon may publish in the future.

Co-authorship network of co-authors of Annie Borel‐Derlon

This figure shows the co-authorship network connecting the top 25 collaborators of Annie Borel‐Derlon. A scholar is included among the top collaborators of Annie Borel‐Derlon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie Borel‐Derlon. Annie Borel‐Derlon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Health-related quality of life in children with von Willebrand disease: results of the French real-life Willebrand Study Health-related Quality of Life study 2025 ·Journal of Thrombosis and Haemostasis ·Jenny Goudemand,Sophie Susen,Claire Berger,Sophie Bayart,Hérvè Chambost,(unknown),Dominique Desprez,S. Claeyssens,Brigitte Pan‐Petesch,(unknown),(unknown),Agnès Veyradier,(unknown),Grégory Marin,Emmanuelle Lagrue,(unknown),Yohann Repessé,Annie Borel‐Derlon,Sylvia von Mackensen	0
2	Management of von Willebrand disease with a factor VIII‐poor von Willebrand factor concentrate: Results from a prospective observational post‐marketing study 2020 ·Journal of Thrombosis and Haemostasis ·Jenny Goudemand,Françoise Bridey,S. Claeyssens,(unknown),Annie Harroche,Dominique Desprez,Claude Négrier,(unknown),Hérvè Chambost,Céline Henriet,Sophie Susen,Annie Borel‐Derlon	12
3	Who Are the Type 2 Von Willebrand Disease Patients? Results from Interim Analysis of the French HRQoL Study: Wish-Qol. 2018 ·Blood ·Annie Borel‐Derlon,Jenny Goudemand,Dominique Desprez,Céline Falaise,(unknown),(unknown),Brigitte Pan‐Petesch,(unknown),(unknown),Agnès Veyradier,Sylvia von Mackensen	0
4	Postauthorization safety study of Clottafact^®, a triply secured fibrinogen concentrate in acquired fibrinogen deficiency: a prospective observational study 2017 ·Vox Sanguinis ·Claude Négrier,A.‐S. Ducloy‐Bouthors,Vincent Piriou,Emmanuel de Maistre,Natalie Stieltjes,Annie Borel‐Derlon,P Colson,Julien Picard,Thierry Lambert,S. Claeyssens,(unknown),A Bertrand,(unknown),F. Fourrier,Yves Ozier,Piérre Siè,Yves Gruel,Z. Tellier	8
5	A novel ELISA-based diagnosis of acquired von Willebrand disease with increased VWF proteolysis 2016 ·Thrombosis and Haemostasis ·Antoine Rauch,Claudine Caron,Flavien Vincent,Emmanuelle Jeanpierre,Catherine Ternisien,Pierre Boisseau,Christophe Zawadzki,Édith Fressinaud,Annie Borel‐Derlon,(unknown),Camille Paris,Cécile Lavenu‐Bombled,Agnès Veyradier,Alexandre Ung,André Vincentelli,Éric Van Belle,Peter J. Lenting,Jenny Goudemand,Sophie Susen	9
6	Influence of factor VIII level and its inhibitor titer on the therapeutic response to corticosteroids alone in the management of acquired hemophilia 2016 ·Medicine ·Mathieu Vautier,Hubert de Boysson,Christian Créveuil,Yohann Repessé,Annie Borel‐Derlon,Xavier Troussard,Gandhi Damaj,Boris Bienvenu,Philippe Gautier,Achille Aouba	12
7	A Laboratory Phenotype/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease 2016 ·Medicine ·Agnès Veyradier,Pierre Boisseau,Édith Fressinaud,Claudine Caron,Catherine Ternisien,(unknown),Christophe Zawadzki,Marc Trossaërt,(unknown),Marie Dreyfus,Roseline d’Oiron,Annie Borel‐Derlon,Sophie Susen,Stéphane Bezieau,Cécile V. Denis,Jenny Goudemand	49
8	Development of inhibitory antibodies to therapeutic factor VIII in severe hemophilia A is associated with microsatellite polymorphisms in the HMOX1 promoter 2013 ·Haematologica ·Yohann Repessé,Ivan Peyron,Jordan D. Dimitrov,Suryasarathi Dasgupta,(unknown),Cathérine Costa,Annie Borel‐Derlon,Benoît Guillet,Roseline d’Oiron,Achille Aouba,C. Rothschild,Johannes Oldenburg,A. Pavlova,Srini V. Kaveri,Sébastien Lacroix‐Desmazes	27
9	Hydrolysis of factor VIII mediated by catalytic antibodies occurs in haemophilia A patients with or without factor VIII inhibitors 2012 ·Haemophilia ·(unknown),(unknown),(unknown),Philippe Gautier,Srini V. Kaveri,Annie Borel‐Derlon,Yohann Repessé	1
10	Patient resources in the therapeutic education of haemophiliacs in France: their skills and roles as defined by consensus of a working group 2010 ·Haemophilia ·(unknown),(unknown),(unknown),C Guérois,(unknown),(unknown),Annie Borel‐Derlon,Pascal Guillon,(unknown),Thierry Lambert,Sandrine Meunier,(unknown),Rémi Gagnayre	14
11	Le syndrome de Willebrand acquis : du diagnostic au traitement 2009 ·Pathologie Biologie ·(unknown),Philippe Gautier,Agnès Lequerrec,Xavier Troussard,Yann Ollivier,Annie Borel‐Derlon	3
12	Factor VIII‐hydrolyzing IgG in acquired and congenital hemophilia 2009 ·FEBS Letters ·Bharath Wootla,(unknown),Jordan D. Dimitrov,Alain Friboulet,Annie Borel‐Derlon,Desirazu N. Rao,Taizo Uda,Jeanne‐Yvonne Borg,Jagadeesh Bayry,Srini V. Kaveri,Sébastien Lacroix‐Desmazes	16
13	Factor VIII Hydrolysis Mediated by Anti-Factor VIII Autoantibodies in Acquired Hemophilia 2008 ·The Journal of Immunology ·Bharath Wootla,Suryasarathi Dasgupta,Jordan D. Dimitrov,Jagadeesh Bayry,H. Lévesque,Jeanne‐Yvonne Borg,Annie Borel‐Derlon,Desirazu N. Rao,Alain Friboulet,Srini V. Kaveri,Sébastien Lacroix‐Desmazes	39
14	Factor VIII (FVIII) gene mutations in 120 patients with hemophilia A: detection of 26 novel mutations and correlation with FVIII inhibitor development 2007 ·Journal of Thrombosis and Haemostasis ·Yohann Repessé,M. Slaoui,(unknown),Philippe Gautier,Cathérine Costa,J.‐M. Costa,J. M. Lavergne,Annie Borel‐Derlon	42
15	Impact of Choice of Treatment for Bleeding Episodes on Inhibitor Outcome in Patients With Mild/Moderate Hemophilia A and Inhibitors 2006 ·Seminars in Hematology ·Roseline d’Oiron,(unknown),J. Reynaud,Kathelijne Peerlinck,Jenny Goudemand,C Guérois,C. Rothschild,Hérvè Chambost,Annie Borel‐Derlon,V. Roussel‐Robert,(unknown),Anne Lienhart,(unknown),Philippe Moreau,Thierry Lambert	18
16	Pharmacokinetic studies on Wilfactin®, a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods 2005 ·Journal of Thrombosis and Haemostasis ·Jenny Goudemand,I. Scharrer,Erik Berntorp,C. A. Lee,Annie Borel‐Derlon,Natalie Stieltjes,Claudine Caron,J M Scherrmann,Françoise Bridey,Z. Tellier,A B Federici,P.M. Mannucci	64
17	Intestinal surgery with activated recombinant factor VII prophylaxis in patients with haemophilia A and high responding inhibitors 2004 ·Blood Coagulation & Fibrinolysis ·(unknown),Thierry Lambert,Natalie Stieltjes,S. Claeyssens,Annie Borel‐Derlon	12
18	Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies 2001 ·BJOG An International Journal of Obstetrics & Gynaecology ·J. Lepercq,Jacqueline Conard,Annie Borel‐Derlon,Jean‐Yves Darmon,(unknown),C Francoual,P. Priollet,(unknown),(unknown),Jean‐François Schved,Michel Tournaire,Jeanne‐Yvonne Borg	195
19	Quelles stratégies thérapeutiques périopératoires dans les maladies constitutionnelles de l'hémostase? 1998 ·Annales Françaises d Anesthésie et de Réanimation ·Annie Borel‐Derlon	1
20	Hémorragie digestive révélatrice d'une angiodysplasie et d'une maladie de von Willebrand de type 2 1997 ·Annales Françaises d Anesthésie et de Réanimation ·C Lefrançois,Laurent Dubus,Joan Maurel,L. Chiche,J. M. Lavergne,Annie Borel‐Derlon	2

About Annie Borel‐Derlon

Annie Borel‐Derlon is a scholar working on Hematology, Internal Medicine and Genetics, having authored 44 papers that have together received 1.3k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (27 papers), Hemophilia Treatment and Research (24 papers) and Blood Coagulation and Thrombosis Mechanisms (12 papers). The work is most often cited by research in Hematology (1.1k citations), Internal Medicine (221 citations) and Genetics (210 citations). Annie Borel‐Derlon has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Jenny Goudemand, Thierry Lambert, Jeanne‐Yvonne Borg, Yohann Repessé, S. Claeyssens, Hérvè Chambost, Sébastien Lacroix‐Desmazes, Srini V. Kaveri, Chantal Rothschild and Jacqueline Conard. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact